dodecanoic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4642 143-07-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dodecanoic acid
  • lauric acid
  • laurostearic acid
  • vulvic acid
  • Molecular weight: 200.32
  • Formula: C12H24O2
  • CLOGP: 5.10
  • LIPINSKI: 1
  • HAC: 2
  • HDO: 1
  • TPSA: 37.30
  • ALOGS: -4.30
  • ROTB: 10

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 3.530 Moderate 0.71
caco2-efflux Caco-2 efflux ratio (BA/AB) 0.492 Moderate 0.71
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 68.707 10^-6 cm/s Moderate 0.71
dh-clint Dog hepatocyte intrinsic clearance 1892.344 uL/min/10^6 cells Moderate 0.71
dppb Dog plasma protein binding (% unbound) 0.150 % Moderate 0.71
fcs-ppb Fetal calf serum protein binding (% unbound) 0.190 % Moderate 0.71
herg hERG pIC50 4.722 pIC50 Moderate 0.71
hh-clint Human hepatocyte intrinsic clearance 4943.107 uL/min/10^6 cells Moderate 0.71
hlm-clint Human liver microsomal intrinsic clearance 32.359 uL/min/mg protein Moderate 0.71
hppb Human plasma protein binding (% unbound) 0.240 % Moderate 0.71
kinase-safety-class ACVR2A,ACVR2B,ACVRL1,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,IKBKB,ITK,JAK1,JAK2,JAK3,MAP2K6,MAP3K14,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM2,PLK1,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ZAP70 59
kinase-selectivity-class AXL,BRAF,CDK4,CDK9,CSNK2A2,EIF2AK3,EPHB4,ERBB2,GRK2,MAP2K6,MAPK10,MAPK12,MAPK7,MAPK8,MTOR,PLK1,PLK2,PLK3,PTK2,SIK2,STK33,TEK,TTK,ZAP70 24
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.292 Moderate 0.71
mh-clint Mouse hepatocyte intrinsic clearance 3872.576 Moderate 0.71
mppb Mouse plasma protein binding (% unbound) 0.510 Moderate 0.71
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 0.155 Moderate 0.71
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 0.620 % Moderate 0.71
rh-clint Rat hepatocyte intrinsic clearance 1069.055 uL/min/10^6 cells Moderate 0.71
rh-fuinc Rat hepatocyte fraction unbound in incubation 60.550 % Moderate 0.71
rppb Rat plasma protein binding (% unbound) 0.280 % Moderate 0.71
solubility-dd Solubility at pH 7.4 in DMSO 51.050 uM Moderate 0.71

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:33282 antibacterial agent
CHEBI has role CHEBI:76924 plant metabolite
CHEBI has role CHEBI:84735 algal metabolite

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 4.76 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
G-protein coupled receptor 84 GPCR AGONIST EC50 5.05 IUPHAR
Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor IC50 4.52 CHEMBL
Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor IC50 4.52 CHEMBL
Peroxisome proliferator-activated receptor delta Nuclear hormone receptor IC50 4.52 CHEMBL
Free fatty acid receptor 1 GPCR EC50 6.12 CHEMBL

External reference:

IDSource
CHEBI:30805 CHEBI
LAU PDB_CHEM_ID
DB03017 DRUGBANK_ID
1363435 RXNORM
006214 NDDF
C0023139 UMLSCUI
3893 PUBCHEM_CID
5534 IUPHAR_LIGAND_ID
C030358 MESH_SUPPLEMENTAL_RECORD_UI
1160N9NU9U UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Vitafol Plus HUMAN PRESCRIPTION DRUG LABEL 17 0642-0092 CAPSULE, LIQUID FILLED 60 mg ORAL UNAPPROVED DRUG OTHER 13 sections